Rashtchizadeh, Nadereh <br/><br/>
Enalapril and losartan affect lipid peroxidation in renal transplant recipients with renin-angiotensin system polymorphisms.  [electronic resource] 

 -  Clinical biochemistry  Feb 2007 
 - 194-200 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0009-9120 
<br/><br/><label>Standard No.: </label>10.1016/j.clinbiochem.2006.10.023  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Angiotensin-Converting Enzyme Inhibitors--administration & dosage<br/>Angiotensinogen--genetics<br/>Cross-Over Studies<br/>Enalapril--administration & dosage<br/>Female<br/>Humans<br/>Kidney Transplantation<br/>Lipid Peroxidation--drug effects<br/>Losartan--administration & dosage<br/>Male<br/>Malondialdehyde--blood<br/>Peptidyl-Dipeptidase A--genetics<br/>Polymerase Chain Reaction<br/>Polymorphism, Genetic<br/>Receptor, Angiotensin, Type 1--genetics<br/>Renin-Angiotensin System--genetics<br/>Sequence Analysis, DNA